All results

11 results for lifestyle study

• Fasting ENHANCE

  Grounded in the principles of geroscience, the proposed Fasting ENHANCE study will test whether a time restricted eating (TRE) regimen can improve cognitive…

  Ages

  65 Years - N/A

  Sexes

  All

• RIN-PF-302

  Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis. Study…

  Ages

  40 Years - N/A

  Sexes

  All

• Terrain Variation Study

  Modern footwear has been implicated as a contributor to foot pathology and changes in the biomechanics of gait. In addition to footwear, the investigators…

  Ages

  18 Years - 100 Years

  Sexes

  All

• TETON

  Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…

  Ages

  40 Years - N/A

  Sexes

  All

• Teton RIN-PF-301

  Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…

  Ages

  40 Years - N/A

  Sexes

  All

• Givinostat Long Term Study

  This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been…

  Ages

  7 Years - N/A

  Sexes

  Male

• TAK-999-3003

  The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin…

  Ages

  18 Years - N/A

  Sexes

  All

• Comprehensive Outcomes for After Cancer Health (COACH)

  This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have…

  Ages

  18 Years - N/A

  Sexes

  All

• Testing Triapine w/ Targeted Radiation-based LU177 vs Lu177 alone in pts w/ metastatic NETs

  This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking…

  Ages

  18 Years - N/A

  Sexes

  All

• GCAptAIN

  This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…

  Ages

  50 Years - N/A

  Sexes

  All